size of infiltrate or scar, corneal structural integrity 6 months [clinicaltrials_resource:b5f1829d6720f6f3cb58c8ca126fab28]
patients not resolving to standard antifungal therapy were assigned to receive adjuvant collagen crosslinking with riboflavin and Ultraviolet-A along with topical medical therapy
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
size of infiltrate or scar, corneal structural integrity 6 months [clinicaltrials_resource:b5f1829d6720f6f3cb58c8ca126fab28]
patients not resolving to standard antifungal therapy were assigned to receive adjuvant collagen crosslinking with riboflavin and Ultraviolet-A along with topical medical therapy
Bio2RDF identifier
b5f1829d6720f6f3cb58c8ca126fab28
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:b5f1829d6720f6f3cb58c8ca126fab28
measure [clinicaltrials_vocabulary:measure]
size of infiltrate or scar, corneal structural integrity
time frame [clinicaltrials_vocabulary:time-frame]
description
patients not resolving to stan ...... g with topical medical therapy
identifier
clinicaltrials_resource:b5f1829d6720f6f3cb58c8ca126fab28
title
size of infiltrate or scar, corneal structural integrity 6 months
@en
type
label
size of infiltrate or scar, co ...... 1829d6720f6f3cb58c8ca126fab28]
@en